Surgery – Controlled release therapeutic device or system
Reexamination Certificate
2006-02-21
2006-02-21
Woo, Julian W. (Department: 3731)
Surgery
Controlled release therapeutic device or system
C424S042000, C435S176000
Reexamination Certificate
active
07001371
ABSTRACT:
An implantable infection shield and system for drug delivery in vascular tissue includes a relatively non-biodegradable porous linked fibrous biomaterial which controls and directs cell growth and angiogenesis from adjacent vascular tissue into the implant. Infection shield embodiments stimulate cell growth and angiogenesis from adjacent vascular tissue which effectively blocks passage of pathogenic microorganisms along percutaneously implanted objects. In embodiments for drug delivery, a reservoir of the same biomaterial may contain either (1) a cell culture system enclosed within a porous sealable interior chamber or (2) a biodegradable matrix in which one or more drugs are dispersed. After implantation of a reservoir of the first embodiment in an organism, cultured cells obtain food and oxygen via diffusion in tissue fluid through the porous walls of the interior chamber, while metabolic products, including drugs, diffuse away from the cell culture in an analogous manner. In a reservoir of the second embodiment, a biodegradable matrix substantially fills the pores (voids), and progressive dissolution of the matrix releases one or more drugs into surrounding tissue fluid. Reservoirs of either embodiment comprise a plurality of voids of a predetermined size effective for stimulating angiogenesis from the surrounding vascular tissue into at least a portion of the reservoir. The reservoir thus acts to couple a source of drugs to the circulatory system of the organism.
REFERENCES:
patent: 3906550 (1975-09-01), Rostoker et al.
patent: 3992725 (1976-11-01), Homsy
patent: 4104426 (1978-08-01), Gonzalez et al.
patent: 4148962 (1979-04-01), Frosch et al.
patent: 4503157 (1985-03-01), Hatahira
patent: 4932099 (1990-06-01), Corwin
patent: 5024671 (1991-06-01), Tu et al.
patent: 5030233 (1991-07-01), Ducheyne
patent: 5098842 (1992-03-01), Nakajima et al.
patent: 5201728 (1993-04-01), Giampapa
patent: 5552352 (1996-09-01), Brun et al.
patent: 5629186 (1997-05-01), Yasukawa et al.
patent: 5681572 (1997-10-01), Seare, Jr.
patent: WO 9110470 (1991-07-01), None
Peppas et al, “New Challenges in Biomaterials,” Science, vol. 263, Mar. 25, 1994, pp. 1715-1720.
Langer et al., “Tissue Engineering,” Science, vol. 260, May 14, 1993, pp. 920-926.
Mooney et al., “Tissue Engineering Using Cells and Synthetic Polymers,” Transportation Reviews, vol. 7, No. 3 (Jul.), 1993, pp. 153-162.
Mooney et al., “Stabilized polyglycolic acid fibre-based tubes for tissue engineering,” Biomaterials 1996, vol. 17, No. 2, pp. 115 124.
Dionne et al., “Transport characterization of membrances for immunoisolation,” Biomaterials 1996, vol. 17, No. 3, pp. 257-266.
Lyman et al., “Characterization of the formation of interfacially photopolymerized thin hydrogels in contact with arterial tissue,” Biomaterials 1996, vol. 17, No. 3, pp. 359-364.
Greisler et al., “Biointeractive polymers and tissue engineered blood vessels,” Biomaterials 1996, vol. 17, No. 3, pp. 329-336.
Healy et al., “Kinetics of bone cell organization and mineralization on materials with patterned surface chemistry,” Biomaterials 1996, vol. 17, No. 2, pp. 195-208.
Dee et al., “Conditions which promote mineralization at the bone-implant interface: a model in vitro study,” Biomaterials 1996, vol. 17, No. 2, pp. 209-215.
Boyan et al., “Role of material surfaces in regulating bone and cartilage cell response,” Biomaterials 1996, vol. 17, No. 2, pp. 137-146.
Misch et al., “Bone-Grafting Materials in Implant Dentistry,” Implant Dentistry, vol. 2, No. 3, pp. 158-167.
Spector, M., “Anorganic Bovine Bone and Ceramic Analogs of Bone Mineral as Implants to Facilitate Bone Regneration,” Clinics in Plastic Surgery, vol. 21, No. 3, Jul. 1994, pp. 437-444.
Hollinger et al., “Bioactive Factors and Biosynthetic Materials in Bone Grafting,” Clinics in Plastic Surgery, vol. 21, No. 3, Jul. 1994, pp. 415-418.
Vacanti et al., “Tissue-Engineered Morphogenesis of Cartilage and Bone by Means of Cell Transportation Using Synthetic Biodegrabale Polymer Matrices,” Clinics in Plastic Surgery, vol. 21, No. 3, Jul. 1994, pp. 445-462.
Zambonin et al., “Biomaterials in orthopaedic surgery: effects of different hydroxyapatites and demineralized bone matrix on proliferation rate and bone matrix synthesis by human osteoblasts,” Biomaterials 1995, vol. 16, No. 5, pp. 397-402.
Vacanti et al., “Bone and Cartilage Reconstruction with Tissue Engineering Approaches,” Otolaryngologic Clinics of North America, Vol. 27, No. 1, Feb. 1994, pp. 263-267.
Kurashina et al., “Osteogenesis in muscle composite graft of hydroxyapatite and autogenous calvarial periosteum: a preliminary report,” Biomaterials 1995, vol. 16, No. 2, pp. 119-123.
Ducheyne et al., “Effect of Bioactive Glass Templates on Osteoblast Proliferation and In Vitro Syntehsis of Bone-Like Tissue,” Journal of Cellular Biochemistry 56, 1994, pp. 162-167.
Kenley et al., “Biotechnology and Bone Graft Substitutes,” Pharmaceutical Research, vol. 10, No. 10, 1993, pp. 1393-1401.
Herrera et al., “Implantation of sepiolite-collagen complexes in surgically created rat calvaria defects,” Biomaterials, vol. 16, No. 8, 1995, pp. 625-631.
Marden et al., “Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats,” Journal of Biomedical Materials Research, vol. 28, 1994, pp. 1127-1138.
Mason, Paul N., “Facial Bone Healing and Bone Grafts,” Clinics in Plastic Surgery, vol. 21, No. 3, Jul. 1994, pp. 331-348.
Habal et al., “Bone Grafts and Bone Induction Substitutes,” Clinics in Plastic Surgery, vol. 21, No. 4, Oct. 1994, pp. 525-542.
Stevenson et al., “The Effect of Osteogenin (A Bone Morphogenetic Protein) on Formation of Bone in Orthopic Segmental Defects in Rats,” The Journal of Bone and Joint Surgery, vol. 76-A, No. 11, Nov. 1994, pp. 1676-1687.
Wolff et al., “Histomorphometric Analysis of the Repair of a Segmental Diaphyseal Defect with Ceramic and Titanium Fibermetal Implants: Effects of Bone Marrow,” Journal of Orthopaedic Research, vol. 12, No. 3, pp. 439-446.
Reddi, A.H., “Symbiosis of Biotechnology and Biomaterials: Applications in Tissue Engineering of Bone and Cartliage,” Journal of Cellular Biochemistry, 56, 1994 , pp. 192-195.
El-Ghannam et al., “Bioactive material template for in vitro synthesis of bone,” Journal of Biomedical Materials Research, vol. 29, 1995, pp. 359-370.
Fujisato et al., “Effect of basic fibroblast growth factor on cartilage regeneration in chondrocyte-seeded collagen sponge scaffold,” Biomaterials, vol. 17, No. 2, 1996, pp. 155-162.
Degroot et al., “Use of porous polyurethanes for meniscal reconstruction and meniscal prostheses,” Biomaterials, vol. 17, No. 2, 1996, pp. 163-173.
Shortkroff et al., “Healing of chondral and osteochondral defects in a canine model: the role of cultured chrondrocytes in regeneration of articular cartilage,” Biomaterials, vol. 17, No. 2, 1996, pp. 147-154.
Casser-Bette et al., “Bone Formation by Osteoblast-Like Cells in a Three-Dimensional Cell Culture,” Calcif Tissue Int, 46, 1990, pp. 46-56.
Hunter et al., “Attachment and proliferation of osteoblast and fibroblasts on biomaterials for orthopaedic use,” Biomaterials, vol. 16, No. 4, 1995, pp. 287-295.
Begley, et al., “The Culture of Human Osteoblasts upon Bone Graft Substitutes,” Bone, 14, 1993, pp. 661-666.
Dixit, V., “Development of a Bioartificial Liver Using Isolated Hepatocytes,” Artificial Organs, vol. 18, No. 5, 1994, pp. 371-384.
Yarmush et al., “Hepatic Tissue Engineering,” Annals New York Academy of Sciences, pp. 238-252.
Wu et al., “Entrapment of Hepatocyte Spheriods in a Hollow Fibe
Halff Glenn A.
Lyles Mark B.
Mallow William A.
McLaughlin Charles A.
Baker & Botts L.L.P.
MED USA
Woo Julian W.
LandOfFree
Porous drug delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Porous drug delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Porous drug delivery system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3681404